Status:
COMPLETED
BIS-guided Fluid Management in HD Patients
Lead Sponsor:
Catholic University of Pelotas
Conditions:
Kidney Failure
Haemodialysis Fluid Adverse Reaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hemodialysis (HD) is life-sustaining in kidney failure. However, adequate fluid status depends on precise estimation of dry weight (DW), which is a goal difficult to achieve. This randomized open labe...
Detailed Description
The study was designed as a randomized controlled open label and parallel trial, including adult chronic kidney disease (CKD) patients (older than 18 years) on in-center HD for longer than three month...
Eligibility Criteria
Inclusion
- CKD diagnosis,
- 18 years or older,
- treated by in-center HD for longer than three months,
- HD treatment in the Dialysis and Transplantation unit of a Brazilian University Hospital.
Exclusion
- less than thrice a week HD session,
- lower limbs amputation,
- pregnancy,
- pacemaker, implantable cardioverter-defibrillator or orthopedic protheses use.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05272800
Start Date
September 1 2019
End Date
September 1 2021
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitário São Francisco de Paula
Pelotas, Rio Grande do Sul, Brazil, 96020-260